Sector: Health Care
Director information for CRINETICS PHARMACEUTICALS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Camille Bedrosian, M.D. | ["Senior Executive Leadership","Therapeutic Area Expertise - Endocrinology","Clinical Development & Medical Affairs","Corporate Strategy & Business Development","Finance & Capital Markets","Human Capital Management & Succession"] | [] | 2026 | ||
| Caren Deardorf | ["Senior Executive Leadership","Regulatory & Compliance","Corporate Strategy & Business Development","Finance & Capital Markets","Human Capital Management & Succession"] | [] | 2026 | ||
| Dana Pizzuti, M.D. | Chief Medical and Development Officer | [] | [] | 2026 | |
| Jeff Knight | Chief Operating Officer | [] | [] | 2026 | |
| Matthew K. Fust | ["Senior Executive Leadership","Regulatory & Compliance","Global Market Access & Commercialization","Corporate Strategy & Business Development","Finance & Capital Markets","Human Capital Management & Succession"] | [] | 2026 | ||
| Rogério Vivaldi Coelho, M.D. | ["Senior Executive Leadership","Regulatory & Compliance","Global Market Access & Commercialization","Corporate Strategy & Business Development","Finance & Capital Markets","Human Capital Management & Succession"] | [] | 2026 | ||
| R. Scott Struthers, Ph.D. | President, Chief Executive Officer and Director | ["Senior Executive Leadership","Therapeutic Area Expertise - Endocrinology","Clinical Development & Medical Affairs","Corporate Strategy & Business Development","Finance & Capital Markets","Human Capital Management & Succession","Technology & Cybersecurity"] | [] | 2026 | |
| Stephanie S. Okey, M.S. | ["Senior Executive Leadership","Regulatory & Compliance","Global Market Access & Commercialization","Corporate Strategy & Business Development","Human Capital Management & Succession","Technology & Cybersecurity"] | [] | 2026 | ||
| Stephen Betz, Ph.D. | Chief Scientific Officer | [] | [] | 2026 | |
| Tobin Schilke | Chief Financial Officer | [] | [] | 2026 | |
| Wendell Wierenga, Ph.D. | ["Senior Executive Leadership","Regulatory & Compliance","Operations & Manufacturing","Corporate Strategy & Business Development","Human Capital Management & Succession","Technology & Cybersecurity"] | [] | 2026 | ||
| Weston Nichols, Ph.D. | ["Senior Executive Leadership","Therapeutic Area Expertise - Endocrinology","Regulatory & Compliance","Operations & Manufacturing","Corporate Strategy & Business Development","Finance & Capital Markets","Technology & Cybersecurity"] | [] | 2026 |
